Bharat Biotech has recently announced the commencement of phase III trials of the COVID-19 vaccine, Covaxin.
It will be the largest clinical trial conducted for a COVID-19 vaccine in India.
The phase III trials will involve 26,000 volunteers across 25 centres in India, being conducted in partnership with ICMR.